First Time Loading...

Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 305 JPY 6.64% Market Closed
Updated: Jun 1, 2024

Sumitomo Pharma Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sumitomo Pharma Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Sumitomo Pharma Co Ltd
TSE:4506
Cash & Cash Equivalents
¥29B
CAGR 3-Years
-47%
CAGR 5-Years
-27%
CAGR 10-Years
2%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash & Cash Equivalents
¥457.8B
CAGR 3-Years
-22%
CAGR 5-Years
-8%
CAGR 10-Years
-4%
Daiichi Sankyo Co Ltd
TSE:4568
Cash & Cash Equivalents
¥647.2B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
13%
Otsuka Holdings Co Ltd
TSE:4578
Cash & Cash Equivalents
¥411.6B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash & Cash Equivalents
¥462.9B
CAGR 3-Years
42%
CAGR 5-Years
30%
CAGR 10-Years
15%
Astellas Pharma Inc
TSE:4503
Cash & Cash Equivalents
¥335.7B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
-2%

See Also

What is Sumitomo Pharma Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
29B JPY

Based on the financial report for Mar 31, 2024, Sumitomo Pharma Co Ltd's Cash & Cash Equivalents amounts to 29B JPY.

What is Sumitomo Pharma Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
2%

Over the last year, the Cash & Cash Equivalents growth was -80%. The average annual Cash & Cash Equivalents growth rates for Sumitomo Pharma Co Ltd have been -47% over the past three years , -27% over the past five years , and 2% over the past ten years .